Scarica l'app Stockscreener
1.08
1.89%
0.02
Dopo l'orario di chiusura:
1.09
0.01
+0.93%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CTSO Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.06
Aprire:
$1.05
Volume 24 ore:
50,467
Relative Volume:
0.30
Capitalizzazione di mercato:
$67.78M
Reddito:
$33.79M
Utile/perdita netta:
$-18.67M
Rapporto P/E:
-3.0151
EPS:
-0.3582
Flusso di cassa netto:
$-19.17M
1 W Prestazione:
+19.73%
1M Prestazione:
+1.89%
6M Prestazione:
-17.56%
1 anno Prestazione:
+20.67%
Intervallo 1D:
$1.04
$1.095
Intervallo di 1 settimana:
$0.8932
$1.22
Portata 52W:
$0.7101
$1.61
Cytosorbents Corp Stock (CTSO) Company Profile
Nome
Cytosorbents Corp
Settore
Industria
Telefono
973-329-8885
Indirizzo
305 COLLEGE ROAD EAST, PRINCETON, NJ
Confronta CTSO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CTSO
Cytosorbents Corp
|
1.08 | 75.13M | 33.79M | -18.67M | -19.17M | -0.3582 |
|
ABT
Abbott Laboratories
|
129.40 | 228.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.50 | 152.25B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
378.95 | 144.00B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 118.82B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.89B | 5.69B | 4.14B | 577.90M | 6.96 |
Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-09-07 | Iniziato | B. Riley Securities | Buy |
| 2021-10-14 | Ripresa | B. Riley Securities | Buy |
| 2020-09-17 | Iniziato | Jefferies | Buy |
| 2020-09-01 | Iniziato | SVB Leerink | Outperform |
| 2017-08-08 | Reiterato | Maxim Group | Buy |
| 2016-10-26 | Iniziato | Aegis Capital | Buy |
| 2016-05-24 | Iniziato | Maxim Group | Buy |
| 2015-10-29 | Aggiornamento | WBB Securities | Speculative Buy → Buy |
| 2015-05-12 | Reiterato | MLV & Co | Buy |
| 2015-04-01 | Reiterato | MLV & Co | Buy |
| 2015-03-05 | Iniziato | MLV & Co | Buy |
| 2015-02-25 | Iniziato | WBB Securities | Speculative Buy |
| 2015-01-27 | Reiterato | H.C. Wainwright | Buy |
Mostra tutto
Cytosorbents Corp Borsa (CTSO) Ultime notizie
What recovery options are there for Cytosorbents CorporationRisk Management & Technical Pattern Based Buy Signals - Newser
How sentiment analysis helps forecast Cytosorbents CorporationQuarterly Portfolio Report & Long-Term Safe Return Strategies - Newser
Is now a turning point for Cytosorbents Corporation2025 Biggest Moves & Daily Stock Trend Watchlist - Newser
Cytosorbents Corp Q2 2025 Earnings Call Highlights - TipRanks
Why Cytosorbents Corporation stock attracts strong analyst attentionFree ROI Driven Equity Selection With Safety - Newser
Published on: 2025-08-12 20:31:12 - Newser
Sector ETF performance correlation with Cytosorbents Corporation [July 2025 Drop Watch]Risk Controlled Swing Trade Alerts - Newser
Is this a good reentry point in Cytosorbents CorporationFree Daily Chart Pattern Stock Forecast - Newser
Is Cytosorbents Corporation reversing from oversold territoryForecast Model for Intraday Buy Signals - Newser
Cytosorbents Corporation (NASDAQ:CTSO) Q2 2025 Earnings Call Transcript - Insider Monkey
Exit strategy if you’re trapped in Cytosorbents CorporationEquity Market Return Forecast Model Update - Newser
Can volume confirm reversal in Cytosorbents CorporationExit Strategy Guide With Risk Control Plan - Newser
What institutions are buying Cytosorbents Corporation stock now5-Year Price Trend Summary and Analysis - Newser
Will Cytosorbents Corporation continue its uptrendFree Long Hold Safe Return Strategy - Newser
Cytosorbents’ (CTSO) “Buy” Rating Reiterated at D. Boral Capital - Defense World
Cytosorbents Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
How to forecast Cytosorbents Corporation trends using time seriesHigh Return Strategy with Low Risk - Newser
How Cytosorbents Corporation stock performs during market volatilityTechnical Screener for High Growth Stocks - Newser
Earnings call transcript: CytoSorbents Q2 2025 revenue miss, stock dips By Investing.com - Investing.com Canada
Earnings call transcript: CytoSorbents Q2 2025 revenue miss, stock dips - Investing.com
CytoSorbents Corp (CTSO) Q2 2025 Earnings Call Highlights: Strat - GuruFocus
CytoSorbents Reports Positive Q2 2025 Financial Results - TipRanks
Cytosorbents Corp reports results for the quarter ended June 30Earnings Summary - TradingView
CytoSorbents: Q2 Earnings Snapshot - San Antonio Express-News
CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update - PR Newswire
Reversal indicators forming on Cytosorbents Corporation stockFree Wealth Building Stock Market Ideas - Newser
What MACD signals say about Cytosorbents CorporationWeekly Market Direction and Sector Summary - Newser
Cytosorbents Corp expected to post a loss of 5 cents a shareEarnings Preview - TradingView
How to recover losses in Cytosorbents Corporation stockBuy and Hold Return Summary with Charts - Newser
Tools to assess Cytosorbents Corporation’s risk profileFree Real Time Alerts Based on AI Prediction - Newser
Is Cytosorbents Corporation stock overvalued or undervaluedAchieve rapid portfolio growth with expert guidance - Jammu Links News
Is it the right time to buy Cytosorbents Corporation stockBuild a portfolio that delivers consistent profits - Jammu Links News
Breakthrough Sepsis Treatment: CytoSorb Therapy Achieves 70% Survival Rate in Latest Clinical Studies - Stock Titan
CytoSorbents Leads a New Era in Sepsis Treatment - Nasdaq
What makes Cytosorbents Corporation stock price move sharplyWeekly High Conviction Trade Setup Analysis - Newser
Should you wait for a breakout in Cytosorbents CorporationFree Wealth Building Stock Market Ideas - Newser
Medical Tech Leader CytoSorbents Sets Q2 2025 Earnings Call: Key Updates Expected on ICU Treatment Solutions - Stock Titan
Why is Cytosorbents Corporation stock attracting strong analyst attentionHigh-profit stock alerts - Jammu Links News
Cytosorbents Corp Azioni (CTSO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.31%
1.36%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):